Literature DB >> 18698020

Overexpression of stromal cell-derived factor 1 and its receptor CXCR4 induces autocrine/paracrine cell proliferation in human pituitary adenomas.

Federica Barbieri1, Adriana Bajetto, Ralf Stumm, Alessandra Pattarozzi, Carola Porcile, Gianluigi Zona, Alessandra Dorcaratto, Jean-Louis Ravetti, Francesco Minuto, Renato Spaziante, Gennaro Schettini, Diego Ferone, Tullio Florio.   

Abstract

PURPOSE: Hypothalamic or locally produced growth factors and cytokines control pituitary development, functioning, and cell division. We evaluated the expression of the chemokine stromal cell-derived factor 1 (SDF1) and its receptor CXCR4 in human pituitary adenomas and normal pituitary tissues and their role in cell proliferation. EXPERIMENTAL
DESIGN: The expression of SDF1 and CXCR4 in 65 human pituitary adenomas and 4 human normal pituitaries was determined by reverse transcription-PCR, immunohistochemistry, and confocal immunofluorescence. The proliferative effect of SDF1 was evaluated in eight fibroblast-free human pituitary adenoma cell cultures.
RESULTS: CXCR4 mRNA was expressed in 92% of growth hormone (GH)-secreting pituitary adenomas (GHoma) and 81% of nonfunctioning pituitary adenomas (NFPA), whereas SDF1 was identified in 63% and 78% of GHomas and NFPAs, respectively. Immunostaining for CXCR4 and SDF1 showed a strong homogenous labeling in all tumoral cells in both GHomas and NFPAs. In normal tissues, CXCR4 and SDF1 were expressed only in a subset of anterior pituitary cells, with a lower expression of SDF1 compared with its cognate receptor. CXCR4 and SDF1 were not confined to a specific cell population in the anterior pituitary but colocalized with discrete subpopulations of GH-, prolactin-, and adrenocorticorticotropic hormone-secreting cells. Conversely, most of the SDF1-containing cells expressed CXCR4. In six of eight pituitary adenoma primary cultures, SDF1 induced a statistically significant increase in DNA synthesis that was prevented by the treatment with the CXCR4 antagonist AMD3100 or somatostatin.
CONCLUSIONS: CXCR4 and SDF1 are overexpressed in human pituitary adenomas and CXCR4 activation may contribute to pituitary cell proliferation and, possibly, to adenoma development in humans.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18698020     DOI: 10.1158/1078-0432.CCR-07-4717

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  33 in total

1.  RNAi targeting CXCR4 inhibits tumor growth through inducing cell cycle arrest and apoptosis.

Authors:  Tao Yu; Yingying Wu; Yi Huang; Chaoran Yan; Ying Liu; Zongsheng Wang; Xiaoyi Wang; Yuming Wen; Changmei Wang; Longjiang Li
Journal:  Mol Ther       Date:  2011-11-22       Impact factor: 11.454

2.  Clinicopathological and therapeutic significance of CXCL12 expression in lung cancer.

Authors:  H Imai; N Sunaga; Y Shimizu; S Kakegawa; K Shimizu; T Sano; T Ishizuka; T Oyama; R Saito; J D Minna; M Mori
Journal:  Int J Immunopathol Pharmacol       Date:  2010 Jan-Mar       Impact factor: 3.219

3.  Evaluation of the combined expression of chemokine SDF-1α and its receptor CXCR4 as a prognostic marker for gastric cancer.

Authors:  Hyo Jin Lee; Song Mei Huang; Ha Yon Kim; Yoon Suk Oh; Ji Young Hwang; Zhe Long Liang; Jeong Ki Min; Hwan Jung Yun; Ji Young Sul; Samyong Kim; Deog Yeon Jo; Jin Man Kim
Journal:  Exp Ther Med       Date:  2011-03-16       Impact factor: 2.447

4.  Chemokine receptor Cxcr4 contributes to kidney fibrosis via multiple effectors.

Authors:  Amy Yuan; Yashang Lee; Uimook Choi; Gilbert Moeckel; Anil Karihaloo
Journal:  Am J Physiol Renal Physiol       Date:  2014-12-23

5.  In vivo and in vitro response to octreotide LAR in a TSH-secreting adenoma: characterization of somatostatin receptor expression and role of subtype 5.

Authors:  Federico Gatto; Federica Barbieri; Lara Castelletti; Marica Arvigo; Alessandra Pattarozzi; Francesca Annunziata; Alexandru Saveanu; Francesco Minuto; Lucio Castellan; Gianluigi Zona; Tullio Florio; Diego Ferone
Journal:  Pituitary       Date:  2011-06       Impact factor: 4.107

Review 6.  CXC chemokines and chemokine receptors in gastric cancer: from basic findings towards therapeutic targeting.

Authors:  Hyo Jin Lee; Ik-Chan Song; Hwan-Jung Yun; Deog-Yeon Jo; Samyong Kim
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

7.  Metformin selectively affects human glioblastoma tumor-initiating cell viability: A role for metformin-induced inhibition of Akt.

Authors:  Roberto Würth; Alessandra Pattarozzi; Monica Gatti; Adirano Bajetto; Alessandro Corsaro; Alessia Parodi; Rodolfo Sirito; Michela Massollo; Cecilia Marini; Gianluigi Zona; Daniela Fenoglio; Gianmario Sambuceti; Gilberto Filaci; Antonio Daga; Federica Barbieri; Tullio Florio
Journal:  Cell Cycle       Date:  2012-12-19       Impact factor: 4.534

8.  Expression of stromal cell-derived factor-1α is an independent risk factor for lymph node metastasis in early gastric cancer.

Authors:  Ik-Chan Song; Zhe-Long Liang; Jung-Chan Lee; Song-Mei Huang; Ha-Yon Kim; Yoon-Suk Oh; Hwan-Jung Yun; Ji-Young Sul; Deog-Yeon Jo; Samyong Kim; Jin-Man Kim; Hyo-Jin Lee
Journal:  Oncol Lett       Date:  2011-08-19       Impact factor: 2.967

9.  Role of chemokine network in the development and progression of ovarian cancer: a potential novel pharmacological target.

Authors:  Federica Barbieri; Adriana Bajetto; Tullio Florio
Journal:  J Oncol       Date:  2009-12-14       Impact factor: 4.375

10.  Stromal cell-derived factor-1 expression in pituitary adenoma tissues and upregulation in hypoxia.

Authors:  Ryutaro Nomura; Daizo Yoshida; Akira Teramoto
Journal:  J Neurooncol       Date:  2009-03-12       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.